Telemedicine Helped Ensure Essential Type 2 Diabetes Care Amid the COVID-19 Pandemic

A new study from the University of Eastern Finland indicates that the COVID-19 pandemic has seriously affected healthcare service usage among patients with 2 type diabetes in North Karelia, Finland, but essential care was continuously provided. The delivery of many essential services was facilitated by processes that strongly relied on telemedicine already before the pandemic.

The outbreak of COVID-19 has challenged healthcare systems and their ability to deliver essential health services. While social distancing measures avoided spreading the virus, they conflicted with good diabetes management, which requires regular follow-up visits to manage the disease and its complications.

In Finland, the government imposed a national lockdown on 16 March, lasting until mid-May 2020. This study used electronic health records to compare healthcare usage in the region of North Karelia in three different periods in 2020 - before, during, and after the lockdown - with the equivalent period in 2019.

In 2020, type 2 diabetes patients sought significantly fewer diabetes- and dental health-related primary healthcare services than the year before the pandemic, with the most significant reduction during the lockdown period. Emergency visits in specialized care dropped significantly during the lockdown period as well, but quickly recovered during the post-lockdown period, reaching the same volume as in 2019.

The high proportion of patients using remote services for diabetes management cushioned the drastic decline in face-to-face appointments - also among elderly patients aged 70 years or older. The proportion of remote consultation among all diabetes-related contacts increased from 56% before the pandemic to 88% during the lockdown period in 2020. Therefore, overall contacts were only 9% fewer in 2020 compared with 2019, while appointments halved.

"The pandemic has highlighted the importance of digital healthcare solutions," says Early Stage Researcher Laura Inglin from the University of Eastern Finland. "In Finland, patients have been able to receive new prescriptions, referrals for examinations, medical opinions, self-care instructions, and lifestyle guidance to monitor and control long-term diseases remotely already for some time. That was a great asset during the pandemic."

"Another asset of Finnish healthcare are high-quality electronic health records, which provide structured and up-to-date information about patients at the point of care. Using routine care data for research helps advance our collective knowledge of health system response to pandemics for future preparedness," Inglin points out.

Inglin L, Wikström K, Lamidi ML, Laatikainen T.
The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland.
BMC Health Serv Res. 2022 Jun 1;22(1):725. doi: 10.1186/s12913-022-08105-z

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...